Order Online! Now! Get your $50 coupon for online order.Order Online! Now! Get your $50 coupon for online order.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Fill out organ-on-a-chip questionnaire to win a FREE gift! Fill out organ-on-a-chip questionnaire to win a FREE gift!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
GMP-ILBH16 | Human | GMP Human IL-1 beta Protein |
|
||
CRS-B002 | Human | ClinMax™ Human IL-1β ELISA Kit | |||
ILB-H82E9 | Human | Biotinylated Human IL-1 beta / IL-1F2 Protein, His,Avitag™ (MALS verified) |
|
|
|
ILB-H51H3 | Human | Human IL-1 beta / IL-1F2 Protein, His Tag (MALS verified) |
|
|
|
ILB-C51H3 | Cynomolgus | Cynomolgus IL-1 beta / IL-1F2 Protein, His Tag |
|
||
ILB-M51H3 | Mouse | Mouse IL-1 beta / IL-1F2 Protein, His Tag (MALS verified) |
|
|
|
ILA-H525c | Human | Human IL-1 beta / IL-1F2 Protein, Fc Tag (MALS verified) |
|
|
|
ILB-H4110 | Human | Human IL-1 beta / IL-1F2 Protein, premium grade |
|
|
Human IL-1 RII, Fc Tag (Cat. No. IL2-H4256) captured on CM5 chip via Anti-human IgG Fc antibodies surface can bind Human IL-1 beta, His Tag (Cat. No. ILB-H51H3) with an affinity constant of 0.571 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Andrographolide/Sodium Hydrogen Sulfite | Approved | Bacterial Infections | Details | |||||||
Rilonacept | KPL-914; RGN-303 | Approved | Regeneron Pharmaceuticals Inc | Arcalyst | United States | Cryopyrin-Associated Periodic Syndromes | Kiniksa Pharmaceuticals Ltd | 2008-02-27 | Genetic Diseases, Inborn; Renal Insufficiency, Chronic; Inflammation; Gout; Scleroderma, Diffuse; Urticaria; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Pericarditis; Still's Disease, Adult-Onset; Arthritis, Juvenile; Deficiency of interleukin-1 receptor antagonist; Muckle-Wells Syndrome (MWS); Scleroderma, Systemic; Schnitzler Syndrome; Anemia; Diabetes Mellitus, Type 1; Familial Mediterranean Fever | Details |
Canakinumab | ACZ-885 | Approved | Novartis Pharma Ag | Ilaris | United States | Cryopyrin-Associated Periodic Syndromes; Muckle-Wells Syndrome (MWS) | Novartis Pharma Ag | 2009-06-17 | Gout; Hyperimmunoglobulin D syndrome; Mucocutaneous Lymph Node Syndrome; Cryopyrin-Associated Periodic Syndromes; Arthritis, Gouty; Cognitive Dysfunction; Sarcoidosis, Pulmonary; Alzheimer Disease; Urticaria; Muscular Dystrophy, Duchenne; Primary Myelofibrosis; Pulmonary Disease, Chronic Obstructive; Dry Eye Syndromes; Lung Neoplasms; Macular Degeneration; Carcinoma, Non-Small-Cell Lung; Anemia, Sickle Cell; Diabetes Mellitus; Behcet Syndrome; Aortic Aneurysm, Abdominal; Peripheral Arterial Disease; Diabetic Retinopathy; Thrombocythemia, Essential; Anemia; Familial Mediterranean Fever; Prediabetic State; Diabetes Mellitus, Type 1; Hepatitis, Alcoholic; Atherosclerosis; Schnitzler Syndrome; Mevalonate Kinase Deficiency; Pyoderma Gangrenosum; Polyarticular Juvenile Idiopathic Arthritis; Diabetes Mellitus, Type 2; Still's Disease, Adult-Onset; Polycythemia Vera; Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Hereditary Autoinflammatory Diseases; Chronic Urticaria; Vasculitis; Muckle-Wells Syndrome ( | Details |
Edaravone/(+)-2-Decanol | SIM-071201; Y-2 | Approved | Jiangsu Simcere Pharmaceutical Co Ltd | Mainland China | Stroke | Nanjing Simcere Dongyuan Pharmaceutical Co Ltd | 2020-07-29 | Brain Infarction; Intracranial Hemorrhages; Cerebral Hemorrhage; Stroke; Alzheimer Disease; Amyotrophic Lateral Sclerosis | Details | |
PG-201 | PG-201 | Approved | Viromed | Layla | South Korea | Osteoarthritis | Pmg Pharm Co Ltd | 2012-01-01 | Osteoarthritis, Knee; Osteoarthritis | Details |
Diacerein | AC-201; AC-203; Art-50; SF-277; CCP-020; KW-4800; AC-201CR | Approved | Verboril, Art, 安必丁, Artrodar, Artrolyt, Cartivix, Fisiodar | Epidermolysis Bullosa, Junctional; Overweight; Epidermolysis Bullosa Dystrophica; Diabetes Mellitus; Osteoarthritis, Hip; Obesity; Arthritis; Osteoarthritis; Diabetes Complications; Diabetes Mellitus, Type 2; Pemphigoid, Bullous; Osteoarthritis, Knee; Epidermolysis Bullosa; Epidermolysis Bullosa Simplex; Coronavirus Disease 2019 (COVID-19); Insulin Resistance; Non-alcoholic Fatty Liver Disease | Details | |||||
Thalidomide | NSC-66847; NSC-527179; K-17; VP-02; FPF-300; FPF300 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Mainland China | Leprosy, Lepromatous; Multiple Myeloma | Changzhou Pharmaceutical Factory | 1982-01-01 | Lymphoma, Mantle-Cell; Leprosy, Lepromatous; Colorectal Neoplasms; Neuroectodermal Tumors, Primitive; Prostatitis; Primary Myelofibrosis; Adenocarcinoma, Clear Cell; Lymphoma, Follicular; Carcinoma, Adenosquamous; Cholangitis, Sclerosing; Osteosarcoma; Endometrial Neoplasms; Xerostomia; Gastrointestinal Hemorrhage; Sarcoma, Ewing; HIV Wasting Syndrome; Pancreatitis, Chronic; Arachnoiditis; Retinoblastoma; Erythema Nodosum; Prostatic Neoplasms; Drug Resistant Epilepsy; Leukemia, Lymphocytic, Chronic, B-Cell; Vascular Malformations; Myelodysplastic-Myeloproliferative Diseases; Stomatitis; Burning Mouth Syndrome; Mycobacterium avium-intracellulare Infection; Amyotrophic Lateral Sclerosis; Neoplasm Metastasis; Carcinoma, Hepatocellular; Melanoma; Sarcoma; Angiodysplasia; Lymphoma, Non-Hodgkin; Appendiceal Neoplasms; Pelvic Pain; Waldenstrom Macroglobulinemia; Glioma; Uterine Neoplasms; Anemia, Sideroblastic; Lung Neoplasms; Mycobacterium Infections; Lupus Erythematosus, Discoid; Anemia, Refractory, with Excess of | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
lutikizumab | ABT-981 | Phase 2 Clinical | Abbvie Inc | Osteoarthritis, Knee; Hidradenitis Suppurativa; Osteoarthritis | Details |
FL-101 | FL-101 | Phase 1 Clinical | Flame Biosciences Inc | Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
Genakumab | Phase 3 Clinical | Changchun GeneScience Pharmaceuticals Co Ltd | Solid tumours; Still's Disease, Adult-Onset; Arthritis, Juvenile; Lung Diseases, Interstitial; Arthritis, Gouty; Gout | Details | |
Ensereptide | PXL-01 | Phase 3 Clinical | Promore Pharma | Post-surgical adhesions; Tissue Adhesions; Cicatrix | Details |
Recombinant humanized monoclonal antibody antiIL-1β(Cp Guojian) | SSGJ-613 | Phase 3 Clinical | Tumor necrosis factor receptor associated periodic syndrome; Arthritis, Juvenile; Arthritis, Gouty; Gout; Inflammation | Details | |
Goflikicept | RPH-104 | Phase 3 Clinical | Trpharm | Still's Disease, Adult-Onset; Familial Mediterranean Fever; Myocardial Infarction; Schnitzler Syndrome; ST Elevation Myocardial Infarction; Coronavirus Disease 2019 (COVID-19); Pericarditis; Gout | Details |
Efprezimod alfa | CD24-Fc; HAS-CD24; CD24-Fc-IgG; MK-7110; MK7110 | Phase 3 Clinical | Oncoimmune Inc | Solid tumours; Hematopoietic stem cell transplantation (HSCT); Leukemia; HIV Infections; Graft vs Host Disease; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dyslipidemias; Leukemia, Myeloid, Acute; Melanoma | Details |
CU-06 | CU-06-EYE; CU-06-IBD; CU-061004; Sac-1004; CU-06-ONCO; CU-06-HAE; CU06-1004 | Phase 2 Clinical | Curacle Co Ltd | Myocardial Infarction; Neoplasms; Lung Diseases; Stroke; Diabetic macular oedema; Colitis, Ulcerative; Diabetic Retinopathy; Crohn Disease; Macular Degeneration; Angioedemas, Hereditary | Details |
DLX-2323 | DLX-2323 | Phase 1 Clinical | Delenex Therapeutics Ag | Inflammation | Details |
Gevokizumab | XMA-005.2; AB-7; XOMA-052; S-78989; VPM-087 | Phase 1 Clinical | Xoma Corp | Arthritis, Rheumatoid; Panuveitis; Labyrinth Diseases; Behcet Syndrome; Uveitis; Osteoarthritis; Colorectal Neoplasms; Cryopyrin-Associated Periodic Syndromes; Hereditary Autoinflammatory Diseases; Diabetes Mellitus, Type 1; Colonic Neoplasms; Diabetes Mellitus, Type 2; Esophageal Neoplasms; Carcinoma, Renal Cell; Stomach Neoplasms; Pyoderma Gangrenosum; Acne Vulgaris | Details |
Tavo-103 | Tavo103; Tavo-103; TAVO-103A; TAVO103A | Phase 1 Clinical | Tavotek Biotherapeutics (Hong Kong) Ltd | Details | |
AK-114 | AK-114; AK114 | Phase 1 Clinical | Zhongshan Akeso Biopharma Co Ltd | Solid tumours; Neoplasms; Inflammation; Neoplasm Metastasis | Details |
This web search service is supported by Google Inc.